Skip to main content
If you continue browsing this website, you agree to our policies:
Terms and Conditions
Privacy & Cookies Policy
Continue
x
Side panel
Home
About
About Open Classroom
EUPATI Fellows
Our Impact
FAQ
Open Classroom
Patient Expert Training Programme
Learning Catalogue
Resources
Glossary
EUPATI Toolbox
Patient Engagement Roadmap
Accessibility Resources
EUPATI website
More
English (en_wp)
English (en_wp)
Português - Portugal (pt)
Ελληνικά (el_wp)
You are currently using guest access
Log in
Side Drawer
EUPATI Open Classroom
Course home
Profile
Calendar
Home
About
Collapse
Expand
About Open Classroom
EUPATI Fellows
Our Impact
FAQ
Open Classroom
Collapse
Expand
Patient Expert Training Programme
Learning Catalogue
Resources
Collapse
Expand
Glossary
EUPATI Toolbox
Patient Engagement Roadmap
Accessibility Resources
EUPATI website
Side Drawer
Expand all
Collapse all
Course home
Open course index
Introduction to Regulatory Affairs
Lesson 4: Concept of pharmacopoeias
Lesson 4: Concept of pharmacopoeias
Section outline
Learning outcomes of this lesson:
Explain the role of modern pharmacopoeias
Describe the roles of the European Directorate for the Quality of Medicines (EDQM)
Select activity 1. History of pharmacopoeias
1. History of pharmacopoeias
Page
Completion
Learners must
View
Select activity 2. Role of modern pharmacopoeias
2. Role of modern pharmacopoeias
Page
Completion
Learners must
View
Select activity 2.1. Impurities controlled by EP monographs
2.1. Impurities controlled by EP monographs
Page
Completion
Learners must
View
Select activity 3. Roles of the European Directorate for the Quality of Medicines (EDQM) and the European Pharmacopoeia (EP) Commission in the medicines regulations system
3. Roles of the European Directorate for the Quality of Medicines (EDQM) and the European Pharmacopoeia (EP) Commission in the medicines regulations system
Page
Completion
Learners must
View
Back to course
Select banner image
×